Polymyosis-Sclerosis Overlap Syndrome. Case report and review of literature
Keywords:
overlapping syndrome, superposition syndrome, polymyositis, sclerodermaAbstract
Introduction: In the syndrome of overlap or overlap there are simultaneously clinical or serological manifestations of two or more systemic autoimmune diseases. They affect 5% of the population with predominance in women.Case Presentation: A 48-year-old man with no personal pathological history. He came with pain in both hands, inflammation in the metacarpal and interphalangeal proximal joints, bilateral and symmetrical, accompanied by morning stiffness that lasted almost all day for 4 months. He was diagnosed with rheumatoid arthritis and started treatment that he abandoned. Then a picture appears that is interpreted as an overlap so it is entered with a florid clinical picture. In laboratory tests: transaminases, creatine phosphokinase, lactate dehydrogenase, were elevated. Clinical and complementary diagnosis of Polymyosis-Sclerosis Overlap Syndrome was diagnosed. Treatment with immunosupers was started. The patient evolved unfavorably and died.
Discussion: The diagnosis of this case was made by clinical manifestations such as sclerodermic fascia, salt and pepper sign, predominantly distal fibrosis in both hands, perioral telangiectasias. Differential diagnoses are systemic autoimmune diseases when presented as single frames. First-line treatment and prognosis depend on overlapping diseases.
Downloads
References
Duró Pujol JC. Reumatología clínica. Barcelona. Editorial Elsevier; 2010; p219
Rojas W, Anaya JM, Cano LE, Aristizábal BH, Gómez LM, Lopera D. Inmunología de Rojas. 17ma Ed. Medellín. Editorial Fondo CIB; 2015; p465-474
Jury EC, D'Cruz D, W Morrow WJ. Autoantibodies and overlap syndromes in autoimmune rheumatic disease. Group Ltd & Association of Clinical Pathologists. [Internet]. 2017. [citado 18 Feb 2018]; 0021-9746. Disponible en: http://jcp.bmj.com/content/54/5/340
Sharp GC, Irwin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. [Internet]. 2015. [citado 18 Feb 2018] 1972;52:148-59. Disponible en: https://www.amjmed.com/article/0002-9343(72)90064-2/fulltext
Lockshin MD, Levine AB, Erkan D. Patients with overlap autoimmune disease differ from those with ‘pure’ disease. Lupus Sci Med. [Internet]. 2015. [citado 18 Feb 2018]; 2(1): e000084. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422903/
Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, W Distler JH, et al. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis. [Internet]. 2015. [citado 18 Feb 2018]; 74(4): 730–737. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392314/
Alba Fériz R, Muñoz Louis R, R. Espinoza L, Khamashta M, Matucci-Cerinc, Sanmartí R, editores. Enfermedades Inflamatorias Reumatológicas. Panamerican League of Associations for Rheumatology: Editorial Producciones Científica Ltda; 2016
Alarcón-Segovia D, Molina L. J, editors. Tratado hispanoamericano de Reumatología. Vol 2. Bogotá: Editorial Nomos; 2007; p918
Larrauri Blas J, Fernández Romero DS, Juri MC, Malbrán A. Miopatías inflamatorias con evolución recidivante. Medicina (B. Aires) [Internet]. 2016 [citado 10 Jul 2018]; 76( 6 ): 379-382. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802016000600012&lng=es
Cappelli S, Bellando-Randone S, Guiducci S, Matucci-Cerinic. Is Immunossuppressive therapy the anchor treatment to achieve remission in systemic sclerosis? Rheumatology Oxford. [Internet]. ? 2014 [citado 10 Jul 2018].; 53(6): 975-87. https://academic.oup.com/rheumatology/article/53/6/975/1824450
Pakozdi A, Nihtyanova S, Moinzadeh P, et al. Clinical and serological hallmarks of systemic sclerosis overlap syndromes. J Rheumatol. [Internet]. 2011. [citado 18 Feb 2018]; 38:2406–9. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/21844148
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
